文献速递免疫规划传染病防控与疫情报告

HIV感染与未感染成人接种四价灭活流感疫苗后的体液免疫应答

Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
PubMed 文献 · Vaccine · 2023-06-30

研究纳入131例HIV感染和55例HIV未感染成人,接种四价灭活流感疫苗后28天,两组抗甲型和乙型流感IgG、IgA均显著升高(P<0.001)。CD4+T细胞计数≤350 cells/mm3的HIV感染者对全部疫苗株的免疫原性低于HIV未感染者(P<0.05),且H1N1、BY和BV血清转化率更低(P<0.05)。

要点

  • HIV感染与未感染成人接种四价灭活流感疫苗后28天IgG和IgA均显著升高(P<0.001)。
  • CD4+T细胞计数≤350 cells/mm3的HIV感染者对全部疫苗株免疫原性低于HIV未感染者(P<0.05)。
  • CD4+T细胞计数≤350 cells/mm3的HIV感染者对H1N1、BY和BV血清转化率低于HIV未感染者(P<0.05)。

核心结论

  • HIV感染成人接种流感疫苗可能有效,尽管抗体应答存在差异。
  • CD4+T细胞计数≤350 cells/mm3的HIV阳性人群较难实现血清转化。
  • 作者认为可针对低CD4+T细胞计数人群制定进一步疫苗接种策略。

研究设计与样本

  • HIV感染成人131例和HIV未感染成人55例接种一剂四价灭活流感疫苗,含H1N1、H3N2、BV和BY株。
  • 采用酶联免疫吸附试验(ELISA)和血凝抑制试验(HAI)分别于第0天和第28天测定IgA、IgG抗体浓度和几何平均滴度(GMT)。
  • 采用简单逻辑回归模型分析血清转化或GMT变化的相关因素。

主要发现

  • HIV感染组和未感染组接种后第28天抗甲型和乙型流感IgG和IgA均显著升高(P<0.001)。
  • 第28天GMT显示,CD4+T细胞计数≤350 cells/mm3的HIV感染者对全部四价灭活流感疫苗株的免疫原性低于HIV未感染者(P<0.05)。
  • CD4+T细胞计数≤350 cells/mm3的HIV感染者第28天对H1N1、BY和BV的血清转化率低于HIV未感染者(P<0.05)。
  • 基线CD4+T细胞计数>350 cell/mm3者较≤350 cells/mm3者对H1N1(OR:2.65, 95%CI:1.07-6.56)和BY(OR:3.43, 95%CI:1.37-8.63)产生抗体应答的可能性更高,对BY血清转化概率更高(OR:3.59, 95%CI:1.03-12.48)。
  • 最低CD4+T细胞计数>350 cell/mm3者较≤350 cell/mm3者对H1N1血清转化概率更高(OR:3.15, 95%CI:1.14-8.73)。

临床怎么用

  • 作者认为HIV感染成人接种流感疫苗可能有效,尽管抗体应答存在差异。
  • 作者指出CD4+T细胞计数≤350 cells/mm3的HIV阳性人群较难实现血清转化。
  • 作者建议可针对低CD4+T细胞计数人群制定进一步疫苗接种策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A limited amount of information is available about the immunogenicity of the quadrivalent inactivated influenza vaccine among human immunodeficiency virus (HIV)-infected individuals, especially in low and middle-income countries (LMICs). METHODS: HIV-infected adults and HIV-uninfected adults received a dose of quadrivalent inactivated influenza vaccine including strains of H1N1, H3N2, BV and BY. Enzyme-linked immunosorbent assay (ELISA) and hemagglutination-inhibition assay (HAI) were used to determine IgA, IgG antibody concentration and geometric mean titers (GMT) at day 0 and day 28, respectively. Associated factors contributing to seroconversion or GMT changes were analyzed using simple logistic regression model. RESULTS: A total of 131 HIV-infected and 55 HIV-uninfected subjects were included in the study. In both HIV-infected and uninfected arms, IgG and IgA against influenza A and B all increased significantly at day 28 after receiving QIV (P < 0.001). GMTs of post-vaccination at day 28 showed that HIV-infected persons with CD4 + T cell counts ≤ 350 cells/mm3 were statistically less immunogenic to all strains of QIV than HIV-uninfected ones (P < 0.05). HIV-infected participants with CD4 + T cell counts ≤ 350 cells/mm3 were less likely to achieve seroconversion to QIV (H1N1, BY and BV) than HIV-uninfected individuals at day 28 after vaccination (P < 0.05). Compared with HIV-infected patients with baseline CD4 + T cell counts ≤ 350 cells/mm3, individuals with baseline CD4 + T cell counts > 350 cell/mm3 seemed more likely to generate antibody responses to H1N1 (OR:2.65, 95 %CI: 1.07-6.56) and BY (OR: 3.43, 95 %CI: 1.37-8.63), and showed a higher probability of seroconversion to BY (OR: 3.59, 95 %CI: 1.03-12.48). Compared with nadir CD4 + T cell count ≤ 350 cell/mm3, individuals with nadir CD4 + T cell count > 350 cell/mm3 showed a higher probability of seroconversion to H1N1(OR: 3.15, 95 %CI: 1.14-8.73). CONCLUSION: Influenza vaccination of HIV-infected adults might be effective despite variable antibody responses. HIV-positive populations with CD4 + T cell counts ≤ 350 are less likely to achieve seroconversion. Further vaccination strategies could be developed for those with low CD4 T cell counts.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu Z, Pang C, Deng Y, et al. Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults. Vaccine. 2023. PMID: 37394372. doi:10.1016/j.vaccine.2023.05.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。